US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Veracyte

40.53

+2.035.27%

Volume:835.67K

Turnover:33.39M

Market Cap:3.26B

PE:29.07

High:40.70

Open:39.67

Low:38.80

Close:38.50

52wk High:60.91

52wk Low:29.46

Shares:80.39M

Float Shares:78.97M

Volume Ratio:0.71

T/O Rate:1.06%

Dividend:- -

Dividend Rate:- -

EPS(TTM):1.39

EPS(LYR):0.8200

ROE:8.77%

ROA:4.09%

PB:2.35

PE(LYR):49.43

Loading ...

Overview Company News Filings

Veracyte posts investor presentation outlining growth strategy for genomic cancer diagnostics portfolio

Needham Raises Price Target on Veracyte to $57 From $48, Keeps Buy Rating

MT Newswires Live

Veracyte assumed with an Outperform at Wolfe Research

Veracyte Is Maintained at Buy by Needham

Veracyte Inc : Needham Raises Target Price to $57 From $48

THOMSON REUTERS

Veracyte posts investor presentation on ASCO findings

Veracyte announces results from Enzamet trial presented at 2026 ASCO meeting

Veracyte - Enzamet Trial Shows Decipher Prostate Test Identifies Chemotherapy Benefit in Metastatic Prostate Cancer

THOMSON REUTERS

Veracyte says ENZAMET trial shows Decipher Prostate test flags metastatic patients who benefit from adding docetaxel

Veracyte Says Prosigna Test Can Help High-Risk Breast Cancer Patients Avoid Chemotherapy

MT Newswires Live

Veracyte says OPTIMA trial shows Prosigna test helps 68% of high-risk breast cancer patients avoid chemotherapy

Veracyte - Optima Trial Shows Prosigna Test Identifies High-Risk Breast Cancer Patients Who Can Avoid Chemotherapy

THOMSON REUTERS

Veracyte Price Target Maintained With a $48.00/Share by Needham

Veracyte VP, Chief Accounting Officer Jonathan Wygant sells 24,000 shares for $1.09 million

Health Rounds: Veracyte genomic test identifies breast cancer patients who can skip chemo

Analysts Are Bullish on These Healthcare Stocks: Veracyte (VCYT), Decibel Cannabis Company (DBCCF)

Veracyte director Robert S. Epstein sells 10,000 shares for $440,129

Veracyte says OPTIMA trial backs Prosigna-guided chemotherapy decisions in breast cancer

Optima Trial Results to Be Presented at Asco Provide New Evidence Supporting Prosigna-Guided Chemotherapy Decisions in Breast Cancer

THOMSON REUTERS

Why Veracyte (VCYT) Is Up 5.4% After Medicare Backs Its TrueMRD Bladder Cancer Test

Simply Wall St.

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://sg.tigerfiesta.com/stock/VCYT/news?page=4"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"VCYT","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"VCYT\",,,,,undefined,":{"symbol":"VCYT","market":"US","secType":"STK","nameCN":"Veracyte","latestPrice":40.53,"timestamp":1789673828849,"preClose":38.5,"halted":0,"volume":835670,"delay":0,"changeRate":0.052727272727272755,"floatShares":78966096,"shares":80390731,"eps":1.394338,"marketStatus":"Trading","change":2.03,"latestTime":"09-17 15:37:17 EDT","open":39.67,"high":40.7,"low":38.8,"amount":33394752.0555,"amplitude":0.049351,"askPrice":40.54,"askSize":100,"bidPrice":40.48,"bidSize":733,"shortable":3,"etf":0,"ttmEps":1.394338,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1789675200000},"marketStatusCode":2,"adr":0,"adrRate":0,"listingDate":1383105600000,"exchange":"NASDAQ","adjPreClose":38.5,"preHourTrading":{"tag":"盘前","latestPrice":39.04,"preClose":38.5,"latestTime":"08:07 EDT","volume":20,"amount":780.05004,"timestamp":1789646823827,"change":0.54,"changeRate":0.014026,"amplitude":0.003896},"postHourTrading":{"tag":"盘后","latestPrice":38.43,"preClose":38.5,"latestTime":"19:30 EDT","volume":45888,"amount":1766665.3625,"timestamp":1789601405318,"change":-0.07,"changeRate":-0.001818,"amplitude":0.001818},"volumeRatio":0.706627,"impliedVol":0.591,"impliedVolPercentile":0.6295},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"VCYT\",,,,,undefined,":{"symbol":"VCYT","floatShares":78966096,"roa":"4.09%","roe":"8.77%","lyrEps":0.82,"volumeRatio":0.706627,"shares":80390731,"dividePrice":0,"high":40.7,"amplitude":0.049351,"preClose":38.5,"low":38.8,"week52Low":29.455,"pbRate":"2.35","psRate":"5.80","week52High":60.91,"institutionHeld":0,"latestPrice":40.53,"committee":0.759904,"eps":1.394338,"divideRate":0,"volume":835670,"delay":0,"ttmEps":1.394338,"open":39.67,"prevYearClose":42.1,"prevWeekClose":40.87,"prevMonthClose":43.19,"prevQuarterClose":58.73,"fiveDayClose":42.03,"twentyDayClose":42.19,"sixtyDayClose":53.79},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/VCYT\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-07-30","symbol":"VCYT","fiscalQuarterEnding":"2026/06","expectedEps":0.29,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1785384000000,"reportTimeType":"post","actualEps":0.37},{"market":"US","date":"2026-05-05","symbol":"VCYT","fiscalQuarterEnding":"2026/03","expectedEps":0.23,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1777953600000,"reportTimeType":"post","actualEps":0.37},{"market":"US","date":"2026-02-25","symbol":"VCYT","fiscalQuarterEnding":"2025/12","expectedEps":0.28,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1771995600000,"reportTimeType":"post","actualEps":0.4},{"market":"US","date":"2026-01-11","symbol":"VCYT","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1768107600000,"reportTimeType":"post","actualEps":null},{"market":"US","date":"2025-11-04","symbol":"VCYT","fiscalQuarterEnding":"2025/09","expectedEps":0.19,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1762232400000,"reportTimeType":"post","actualEps":0.38}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"VCYT\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"VCYT\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.4615,"buy":0.3846,"hold":0.0769,"sell":0.0769,"strongSell":0,"meanLabel":"BUY","meanPercent":0.3846,"analysts":13,"updateTime":1784174400000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/VCYT\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"VCYT","date":"2026-09-16","current":27.611669,"percent":0.680066,"low":-385.825732,"twenty":-48.337466,"median":-27.943593,"eighty":57.374001,"high":128.754434,"avg":-21.059489,"sd":99.105231,"marketCap":3226883942},"quantilePoints":[{"date":"2021-09-17","current":-57.515283,"twenty":-91.262492,"median":-37.282622,"eighty":-7.433589,"marketCap":3627718963},{"date":"2021-09-24","current":-54.909122,"twenty":-91.262492,"median":-37.675398,"eighty":-7.452597,"marketCap":3463337947},{"date":"2021-10-01","current":-52.437762,"twenty":-91.262492,"median":-37.857434,"eighty":-7.469818,"marketCap":3307459398},{"date":"2021-10-08","current":-46.652533,"twenty":-91.262492,"median":-38.378258,"eighty":-7.482161,"marketCap":2942561885},{"date":"2021-10-15","current":-50.730277,"twenty":-91.262492,"median":-38.729689,"eighty":-7.508673,"marketCap":3199761491},{"date":"2021-10-22","current":-52.123225,"twenty":-91.262492,"median":-39.246498,"eighty":-7.518204,"marketCap":3287620310},{"date":"2021-10-29","current":-53.785776,"twenty":-91.262492,"median":-39.473894,"eighty":-7.52613,"marketCap":3392484061},{"date":"2021-11-05","current":-56.122335,"twenty":-91.262492,"median":-39.856333,"eighty":-7.536946,"marketCap":3539860144},{"date":"2021-11-12","current":-46.808569,"twenty":-91.262492,"median":-40.393814,"eighty":-7.546315,"marketCap":3420723435},{"date":"2021-11-19","current":-47.926531,"twenty":-91.262492,"median":-40.827934,"eighty":-7.571063,"marketCap":3502422956},{"date":"2021-11-26","current":-40.402163,"twenty":-91.262492,"median":-41.146277,"eighty":-7.587331,"marketCap":2952549656},{"date":"2021-12-03","current":-35.084554,"twenty":-91.262492,"median":-41.146277,"eighty":-7.618881,"marketCap":2563944107},{"date":"2021-12-10","current":-38.127354,"twenty":-91.262492,"median":-41.146277,"eighty":-7.640848,"marketCap":2786308891},{"date":"2021-12-17","current":-43.736605,"twenty":-91.262492,"median":-41.231045,"eighty":-7.697542,"marketCap":3196227359},{"date":"2021-12-23","current":-39.361972,"twenty":-91.262492,"median":-41.315975,"eighty":-7.725635,"marketCap":2876533580},{"date":"2021-12-31","current":-40.052192,"twenty":-91.262492,"median":-41.315975,"eighty":-7.746237,"marketCap":2926974154},{"date":"2022-01-07","current":-32.644481,"twenty":-91.224661,"median":-41.320023,"eighty":-7.765318,"marketCap":2385626021},{"date":"2022-01-14","current":-29.494745,"twenty":-91.224661,"median":-41.320023,"eighty":-7.800551,"marketCap":2155446501},{"date":"2022-01-21","current":-26.20891,"twenty":-91.224661,"median":-41.320023,"eighty":-7.817638,"marketCap":1915320951},{"date":"2022-01-28","current":-26.325567,"twenty":-91.224661,"median":-41.320023,"eighty":-7.877447,"marketCap":1923846118},{"date":"2022-02-04","current":-27.861549,"twenty":-91.224661,"median":-41.320023,"eighty":-7.937202,"marketCap":2036094156},{"date":"2022-02-11","current":-29.105889,"twenty":-91.224661,"median":-41.320023,"eighty":-8.057858,"marketCap":2127029276},{"date":"2022-02-18","current":-24.624321,"twenty":-91.224661,"median":-41.320023,"eighty":-8.118793,"marketCap":1799520760},{"date":"2022-02-25","current":-26.179746,"twenty":-91.224661,"median":-41.320023,"eighty":-8.137105,"marketCap":1913189659},{"date":"2022-03-04","current":-23.336354,"twenty":-91.224661,"median":-41.320023,"eighty":-8.153724,"marketCap":1763364885},{"date":"2022-03-11","current":-22.422126,"twenty":-91.224661,"median":-41.320023,"eighty":-8.153724,"marketCap":1694283142},{"date":"2022-03-18","current":-26.663386,"twenty":-91.224661,"median":-41.320023,"eighty":-8.153724,"marketCap":2014765452},{"date":"2022-03-25","current":-25.409858,"twenty":-91.224661,"median":-41.320023,"eighty":-8.153724,"marketCap":1920045125},{"date":"2022-04-01","current":-27.351413,"twenty":-91.224661,"median":-41.320023,"eighty":-8.153724,"marketCap":2066754804},{"date":"2022-04-08","current":-24.297706,"twenty":-91.224661,"median":-41.320023,"eighty":-8.153724,"marketCap":1836007541},{"date":"2022-04-14","current":-22.761427,"twenty":-91.224661,"median":-41.320023,"eighty":-8.153724,"marketCap":1719921727},{"date":"2022-04-22","current":-20.537122,"twenty":-91.224661,"median":-41.320023,"eighty":-8.178289,"marketCap":1551846560},{"date":"2022-04-29","current":-19.354001,"twenty":-91.224661,"median":-41.320023,"eighty":-8.181561,"marketCap":1462446398},{"date":"2022-05-06","current":-27.358006,"twenty":-91.224661,"median":-41.320023,"eighty":-8.208642,"marketCap":1317452124},{"date":"2022-05-13","current":-26.942591,"twenty":-91.224661,"median":-41.320023,"eighty":-8.276391,"marketCap":1297447428},{"date":"2022-05-20","current":-27.254152,"twenty":-91.224661,"median":-41.320023,"eighty":-8.366376,"marketCap":1312450950},{"date":"2022-05-27","current":-28.025636,"twenty":-91.224661,"median":-41.320023,"eighty":-8.476091,"marketCap":1349602529},{"date":"2022-06-03","current":-25.399624,"twenty":-91.224661,"median":-41.320023,"eighty":-8.585431,"marketCap":1223144272},{"date":"2022-06-10","current":-24.227561,"twenty":-91.224661,"median":-41.320023,"eighty":-8.77283,"marketCap":1166702451},{"date":"2022-06-17","current":-25.221589,"twenty":-91.224661,"median":-41.320023,"eighty":-9.855819,"marketCap":1214570831},{"date":"2022-06-24","current":-33.737584,"twenty":-91.262492,"median":-41.324071,"eighty":-10.019151,"marketCap":1624667099},{"date":"2022-07-01","current":-31.304443,"twenty":-91.262492,"median":-41.324071,"eighty":-10.565025,"marketCap":1507496737},{"date":"2022-07-08","current":-37.980745,"twenty":-91.262492,"median":-41.324071,"eighty":-10.960462,"marketCap":1829000780},{"date":"2022-07-15","current":-39.597894,"twenty":-91.262492,"median":-41.324071,"eighty":-11.08511,"marketCap":1906876204},{"date":"2022-07-22","current":-36.408105,"twenty":-91.262492,"median":-41.324071,"eighty":-11.633973,"marketCap":1753268717},{"date":"2022-07-29","current":-39.078626,"twenty":-91.262492,"median":-41.324071,"eighty":-12.082717,"marketCap":1881870334},{"date":"2022-08-05","current":-41.047649,"twenty":-91.262492,"median":-41.324071,"eighty":-12.243479,"marketCap":1996968112},{"date":"2022-08-12","current":-38.325851,"twenty":-91.262492,"median":-41.324071,"eighty":-12.587971,"marketCap":1864552663},{"date":"2022-08-19","current":-31.925949,"twenty":-91.262492,"median":-41.324071,"eighty":-12.988602,"marketCap":1553197420},{"date":"2022-08-26","current":-31.396302,"twenty":-91.262492,"median":-41.324071,"eighty":-13.149364,"marketCap":1527430090},{"date":"2022-09-02","current":-28.218419,"twenty":-91.262492,"median":-41.324071,"eighty":-13.540343,"marketCap":1372826107},{"date":"2022-09-09","current":-29.351276,"twenty":-91.262492,"median":-41.324071,"eighty":-13.833244,"marketCap":1427939564},{"date":"2022-09-16","current":-27.173838,"twenty":-91.262492,"median":-41.324071,"eighty":-14.159873,"marketCap":1322007205},{"date":"2022-09-23","current":-24.393191,"twenty":-91.262492,"median":-41.324071,"eighty":-14.478846,"marketCap":1186728720},{"date":"2022-09-30","current":-24.422615,"twenty":-91.262492,"median":-41.324071,"eighty":-14.790164,"marketCap":1188160238},{"date":"2022-10-07","current":-25.84972,"twenty":-91.262492,"median":-41.324071,"eighty":-15.050446,"marketCap":1257588879},{"date":"2022-10-14","current":-22.966086,"twenty":-91.262492,"median":-41.324071,"eighty":-15.25459,"marketCap":1117300079},{"date":"2022-10-21","current":-23.289759,"twenty":-91.262492,"median":-41.324071,"eighty":-15.583771,"marketCap":1133046781},{"date":"2022-10-28","current":-28.409681,"twenty":-91.262492,"median":-41.324071,"eighty":-15.919051,"marketCap":1382130976},{"date":"2022-11-04","current":-40.452678,"twenty":-91.262492,"median":-41.324071,"eighty":-16.688819,"marketCap":1749335604},{"date":"2022-11-11","current":-49.678145,"twenty":-91.262492,"median":-41.386088,"eighty":-17.169567,"marketCap":2148281706},{"date":"2022-11-18","current":-43.107489,"twenty":-91.262492,"median":-41.758191,"eighty":-17.412803,"marketCap":1864140238},{"date":"2022-11-25","current":-43.472525,"twenty":-91.262492,"median":-42.093687,"eighty":-17.842042,"marketCap":1879925875},{"date":"2022-12-02","current":-48.35074,"twenty":-91.262492,"median":-42.327795,"eighty":-18.10817,"marketCap":2090879389},{"date":"2022-12-09","current":-44.285561,"twenty":-91.262492,"median":-42.974748,"eighty":-18.75489,"marketCap":1915084794},{"date":"2022-12-16","current":-45.480226,"twenty":-91.262492,"median":-43.472525,"eighty":-19.425491,"marketCap":1966746879},{"date":"2022-12-23","current":-40.784529,"twenty":-91.262492,"median":-43.720153,"eighty":-19.972499,"marketCap":1763686183},{"date":"2022-12-30","current":-39.374161,"twenty":-91.262492,"median":-43.720153,"eighty":-20.35166,"marketCap":1702696222},{"date":"2023-01-06","current":-37.150757,"twenty":-91.262492,"median":-43.720153,"eighty":-20.503192,"marketCap":1606547341},{"date":"2023-01-13","current":-44.169413,"twenty":-91.262492,"median":-43.732402,"eighty":-20.769453,"marketCap":1910062091},{"date":"2023-01-20","current":-41.298899,"twenty":-91.262492,"median":-43.736605,"eighty":-21.742511,"marketCap":1785929581},{"date":"2023-01-27","current":-43.190451,"twenty":-91.262492,"median":-43.736605,"eighty":-22.438376,"marketCap":1867727882},{"date":"2023-02-03","current":-44.252376,"twenty":-91.262492,"median":-43.837562,"eighty":-22.780131,"marketCap":1913649736},{"date":"2023-02-10","current":-40.4029,"twenty":-91.262492,"median":-43.837562,"eighty":-22.930786,"marketCap":1747183017},{"date":"2023-02-17","current":-42.244675,"twenty":-91.262492,"median":-43.84417,"eighty":-23.317716,"marketCap":1826828732},{"date":"2023-02-24","current":-46.670784,"twenty":-91.262492,"median":-43.920524,"eighty":-23.6458,"marketCap":1706283866},{"date":"2023-03-03","current":-48.823359,"twenty":-91.262492,"median":-44.252376,"eighty":-23.913066,"marketCap":1784981994},{"date":"2023-03-10","current":-41.620236,"twenty":-91.262492,"median":-44.319889,"eighty":-24.309016,"marketCap":1521635823},{"date":"2023-03-17","current":-44.26467,"twenty":-91.262492,"median":-44.699024,"eighty":-24.439109,"marketCap":1618316335},{"date":"2023-03-24","current":-43.356879,"twenty":-91.262492,"median":-44.721105,"eighty":-24.592861,"marketCap":1585127502},{"date":"2023-03-31","current":-44.00812,"twenty":-91.224661,"median":-44.710065,"eighty":-24.693937,"marketCap":1608936882},{"date":"2023-04-06","current":-42.409619,"twenty":-91.224661,"median":-44.710065,"eighty":-24.843197,"marketCap":1550495677},{"date":"2023-04-14","current":-44.99485,"twenty":-91.262492,"median":-44.721105,"eighty":-25.139143,"marketCap":1645011700},{"date":"2023-04-21","current":-45.001813,"twenty":-91.262492,"median":-44.881973,"eighty":-25.257948,"marketCap":1645266294},{"date":"2023-04-28","current":-44.130683,"twenty":-91.262492,"median":-44.971343,"eighty":-25.392408,"marketCap":1613417760},{"date":"2023-05-05","current":-44.071287,"twenty":-91.262492,"median":-44.99485,"eighty":-25.446669,"marketCap":1611246270},{"date":"2023-05-12","current":-56.561661,"twenty":-91.262492,"median":-45.21193,"eighty":-25.734923,"marketCap":1707596538},{"date":"2023-05-19","current":-58.984361,"twenty":-91.262492,"median":-45.264522,"eighty":-25.841782,"marketCap":1780737866},{"date":"2023-05-26","current":-61.143203,"twenty":-91.262492,"median":-45.56119,"eighty":-25.960414,"marketCap":1845913306},{"date":"2023-06-02","current":-62.822303,"twenty":-91.262492,"median":-45.690608,"eighty":-26.040937,"marketCap":1896605315},{"date":"2023-06-08","current":-63.421981,"twenty":-91.262492,"median":-45.878447,"eighty":-26.182052,"marketCap":1914709604},{"date":"2023-06-16","current":-63.613878,"twenty":-91.338153,"median":-46.043792,"eighty":-26.252633,"marketCap":1920502977},{"date":"2023-06-23","current":-63.565904,"twenty":-91.375983,"median":-46.661659,"eighty":-26.461667,"marketCap":1919054634},{"date":"2023-06-30","current":-62.030727,"twenty":-91.398369,"median":-46.819367,"eighty":-26.576376,"marketCap":1872707654},{"date":"2023-07-07","current":-55.698124,"twenty":-91.398369,"median":-46.977662,"eighty":-26.650444,"marketCap":1681526362},{"date":"2023-07-14","current":-68.411305,"twenty":-91.409562,"median":-47.534331,"eighty":-26.914684,"marketCap":2065337289},{"date":"2023-07-21","current":-67.211948,"twenty":-91.420755,"median":-47.73791,"eighty":-27.058428,"marketCap":2029128711},{"date":"2023-07-28","current":-65.340952,"twenty":-91.443299,"median":-47.926531,"eighty":-27.21209,"marketCap":1972643329},{"date":"2023-08-04","current":-61.119216,"twenty":-91.443299,"median":-48.35074,"eighty":-27.388744,"marketCap":1845189134},{"date":"2023-08-11","current":-63.688018,"twenty":-91.443299,"median":-48.910457,"eighty":-27.56212,"marketCap":1850773813},{"date":"2023-08-18","current":-61.034351,"twenty":-91.443299,"median":-49.678145,"eighty":-28.078838,"marketCap":1773658238},{"date":"2023-08-25","current":-62.861877,"twenty":-91.443299,"median":-50.719044,"eighty":-28.268442,"marketCap":1826766134},{"date":"2023-09-01","current":-66.09134,"twenty":-91.443299,"median":-51.572786,"eighty":-28.726088,"marketCap":1920614335},{"date":"2023-09-08","current":-63.412638,"twenty":-91.443299,"median":-52.145692,"eighty":-29.078669,"marketCap":1842771254},{"date":"2023-09-15","current":-63.112223,"twenty":-91.443299,"median":-52.482696,"eighty":-29.330892,"marketCap":1834041189},{"date":"2023-09-22","current":-56.578192,"twenty":-91.443299,"median":-52.696131,"eighty":-29.577122,"marketCap":1644162271},{"date":"2023-09-29","current":-57.354265,"twenty":-91.443299,"median":-53.606041,"eighty":-30.172229,"marketCap":1666714940},{"date":"2023-10-06","current":-53.448868,"twenty":-91.443299,"median":-53.774317,"eighty":-30.964578,"marketCap":1553224093},{"date":"2023-10-13","current":-52.622726,"twenty":-91.448974,"median":-54.089079,"eighty":-31.463943,"marketCap":1529216413},{"date":"2023-10-20","current":-52.04693,"twenty":-91.448974,"median":-54.089079,"eighty":-32.314481,"marketCap":1512483788},{"date":"2023-10-27","current":-51.12065,"twenty":-91.478337,"median":-54.190181,"eighty":-32.955566,"marketCap":1485566088},{"date":"2023-11-03","current":-55.952327,"twenty":-91.478337,"median":-54.259195,"eighty":-33.711668,"marketCap":1625974636},{"date":"2023-11-10","current":-31.391487,"twenty":-91.478337,"median":-54.312664,"eighty":-34.025402,"marketCap":1568161736},{"date":"2023-11-17","current":-36.128721,"twenty":-91.478337,"median":-54.312664,"eighty":-34.724031,"marketCap":1804810270},{"date":"2023-11-24","current":-38.292643,"twenty":-91.478337,"median":-54.312664,"eighty":-35.17226,"marketCap":1912908983},{"date":"2023-12-01","current":-37.429999,"twenty":-91.478337,"median":-54.312664,"eighty":-35.709925,"marketCap":1869815577},{"date":"2023-12-08","current":-36.581975,"twenty":-91.460325,"median":-54.297773,"eighty":-36.123643,"marketCap":1827452568},{"date":"2023-12-15","current":-41.59701,"twenty":-91.460325,"median":-54.297773,"eighty":-36.534748,"marketCap":2077978639},{"date":"2023-12-22","current":-40.953682,"twenty":-91.460325,"median":-54.297773,"eighty":-36.675157,"marketCap":2045841184},{"date":"2023-12-27","current":-41.7286,"twenty":-91.460325,"median":-54.297773,"eighty":-36.689994,"marketCap":2084552210},{"date":"2024-01-05","current":-37.342272,"twenty":-91.51436,"median":-54.527362,"eighty":-36.858194,"marketCap":1865433197},{"date":"2024-01-12","current":-39.389225,"twenty":-91.51436,"median":-54.527362,"eighty":-37.070317,"marketCap":1967688736},{"date":"2024-01-19","current":-37.356893,"twenty":-91.532372,"median":-54.58323,"eighty":-37.355359,"marketCap":1866163594},{"date":"2024-01-26","current":-38.044084,"twenty":-91.51436,"median":-54.527362,"eighty":-37.429999,"marketCap":1900492239},{"date":"2024-02-02","current":-37.079092,"twenty":-91.51436,"median":-54.527362,"eighty":-37.476327,"marketCap":1852286056},{"date":"2024-02-09","current":-36.552733,"twenty":-91.51436,"median":-54.527362,"eighty":-37.476327,"marketCap":1825991775},{"date":"2024-02-16","current":-36.991366,"twenty":-91.51436,"median":-54.527362,"eighty":-37.515454,"marketCap":1847903676},{"date":"2024-02-23","current":-23.893683,"twenty":-91.51436,"median":-54.527362,"eighty":-37.515454,"marketCap":1777785592},{"date":"2024-03-01","current":-23.76011,"twenty":-91.496349,"median":-54.420013,"eighty":-37.438772,"marketCap":1767847231},{"date":"2024-03-08","current":-22.952973,"twenty":-91.496349,"median":-54.420013,"eighty":-37.438772,"marketCap":1707792973},{"date":"2024-03-15","current":-21.449679,"twenty":-91.496349,"median":-54.420013,"eighty":-37.412453,"marketCap":1595941916},{"date":"2024-03-22","current":-21.762445,"twenty":-91.496349,"median":-54.420013,"eighty":-37.336424,"marketCap":1619212942},{"date":"2024-03-28","current":-21.913783,"twenty":-91.496349,"median":-54.420013,"eighty":-37.186712,"marketCap":1630473115},{"date":"2024-04-05","current":-20.349954,"twenty":-91.51436,"median":-54.527362,"eighty":-36.91826,"marketCap":1514117989},{"date":"2024-04-12","current":-20.91495,"twenty":-91.51436,"median":-54.527362,"eighty":-36.816545,"marketCap":1556155970},{"date":"2024-04-19","current":-19.3713,"twenty":-91.51436,"median":-54.527362,"eighty":-36.630648,"marketCap":1441302201},{"date":"2024-04-26","current":-20.01504,"twenty":-91.496349,"median":-54.420013,"eighty":-36.570278,"marketCap":1489199053},{"date":"2024-05-03","current":-20.744541,"twenty":-91.496349,"median":-54.224688,"eighty":-36.251538,"marketCap":1543476842},{"date":"2024-05-10","current":-23.132782,"twenty":-91.496349,"median":-53.830116,"eighty":-35.868466,"marketCap":1577123684},{"date":"2024-05-17","current":-26.238832,"twenty":-91.496349,"median":-53.653277,"eighty":-35.501067,"marketCap":1788884838},{"date":"2024-05-24","current":-23.368259,"twenty":-91.496349,"median":-53.355546,"eighty":-34.872412,"marketCap":1593177778},{"date":"2024-05-31","current":-23.536456,"twenty":-91.496349,"median":-52.709497,"eighty":-33.901589,"marketCap":1604644989},{"date":"2024-06-07","current":-24.00741,"twenty":-91.496349,"median":-52.595031,"eighty":-33.456179,"marketCap":1636753178},{"date":"2024-06-14","current":-24.43351,"twenty":-91.51436,"median":-52.26926,"eighty":-32.638648,"marketCap":1665803445},{"date":"2024-06-21","current":-24.399871,"twenty":-91.532372,"median":-52.100758,"eighty":-32.295091,"marketCap":1663510003},{"date":"2024-06-28","current":-24.657774,"twenty":-91.613549,"median":-51.946792,"eighty":-31.731749,"marketCap":1681093059},{"date":"2024-07-05","current":-24.074689,"twenty":-91.613549,"median":-51.12065,"eighty":-31.356669,"marketCap":1641340062},{"date":"2024-07-12","current":-25.308138,"twenty":-91.613549,"median":-50.662876,"eighty":-30.584177,"marketCap":1725432939},{"date":"2024-07-15","current":-25.509975,"twenty":-91.613549,"median":-50.619958,"eighty":-30.376556,"marketCap":1739193592},{"date":"2024-08-02","current":-25.734239,"twenty":-91.460325,"median":-49.281162,"eighty":-30.057472,"marketCap":1754483206},{"date":"2024-08-09","current":-42.598386,"twenty":-90.077119,"median":-48.628371,"eighty":-29.971094,"marketCap":2302059356},{"date":"2024-08-16","current":-46.421864,"twenty":-89.655421,"median":-48.296183,"eighty":-29.971094,"marketCap":2508683969},{"date":"2024-08-23","current":-44.147676,"twenty":-88.628983,"median":-47.792212,"eighty":-29.971094,"marketCap":2385784571},{"date":"2024-08-30","current":-45.39848,"twenty":-87.513126,"median":-47.536017,"eighty":-29.971094,"marketCap":2453379240},{"date":"2024-09-06","current":-42.314112,"twenty":-86.96433,"median":-46.977662,"eighty":-29.971094,"marketCap":2286696931},{"date":"2024-09-13","current":-43.238001,"twenty":-86.01184,"median":-46.789766,"eighty":-29.971094,"marketCap":2336624812},{"date":"2024-09-20","current":-50.103206,"twenty":-85.352102,"median":-46.781191,"eighty":-29.971094,"marketCap":2707627371},{"date":"2024-09-27","current":-47.630027,"twenty":-84.105714,"median":-46.781191,"eighty":-29.971094,"marketCap":2573974275},{"date":"2024-10-04","current":-46.862488,"twenty":-82.553824,"median":-46.781191,"eighty":-29.971094,"marketCap":2532495728},{"date":"2024-10-11","current":-45.867531,"twenty":-80.968196,"median":-46.676355,"eighty":-29.971094,"marketCap":2478727241},{"date":"2024-10-18","current":-48.767121,"twenty":-79.854884,"median":-46.676355,"eighty":-29.971094,"marketCap":2635423974},{"date":"2024-10-25","current":-46.592428,"twenty":-78.335923,"median":-46.62248,"eighty":-29.971094,"marketCap":2517901424},{"date":"2024-10-31","current":-49.747864,"twenty":-76.94338,"median":-46.62248,"eighty":-29.971094,"marketCap":2688424340},{"date":"2024-11-08","current":-309.469649,"twenty":-76.100367,"median":-46.592428,"eighty":-29.902465,"marketCap":2868164710},{"date":"2024-11-15","current":-309.73093,"twenty":-76.100367,"median":-46.592428,"eighty":-29.902465,"marketCap":2870586258},{"date":"2024-11-22","current":-325.618856,"twenty":-76.100367,"median":-46.592428,"eighty":-29.902465,"marketCap":3017835553},{"date":"2024-11-29","current":-359.150741,"twenty":-76.100367,"median":-46.592428,"eighty":-29.902465,"marketCap":3328609065},{"date":"2024-12-06","current":-358.230913,"twenty":-76.100367,"median":-46.592428,"eighty":-29.902465,"marketCap":3320084106},{"date":"2024-12-13","current":-371.275737,"twenty":-76.100367,"median":-46.592428,"eighty":-29.902465,"marketCap":3440983527},{"date":"2024-12-20","current":-326.705924,"twenty":-76.100367,"median":-46.592428,"eighty":-29.902465,"marketCap":3027910505},{"date":"2024-12-27","current":-342.426608,"twenty":-76.100367,"median":-46.592428,"eighty":-29.902465,"marketCap":3173609807},{"date":"2025-01-03","current":-338.161955,"twenty":-76.100367,"median":-46.592428,"eighty":-29.902465,"marketCap":3134084996},{"date":"2025-01-10","current":-366.091256,"twenty":-75.921084,"median":-46.507146,"eighty":-29.833836,"marketCap":3392933757},{"date":"2025-01-17","current":-343.680918,"twenty":-75.921084,"median":-46.507146,"eighty":-29.833836,"marketCap":3185234751},{"date":"2025-01-24","current":-368.516255,"twenty":-75.921084,"median":-46.507146,"eighty":-29.833836,"marketCap":3415408650},{"date":"2025-01-31","current":-385.825732,"twenty":-75.921084,"median":-46.507146,"eighty":-29.833836,"marketCap":3575832882},{"date":"2025-02-07","current":-363.749877,"twenty":-75.921084,"median":-46.507146,"eighty":-29.833836,"marketCap":3371233861},{"date":"2025-02-14","current":-331.054199,"twenty":-75.921084,"median":-46.507146,"eighty":-29.833836,"marketCap":3068210312},{"date":"2025-02-21","current":-343.262815,"twenty":-75.921084,"median":-46.507146,"eighty":-29.833836,"marketCap":3181359770},{"date":"2025-02-28","current":108.649741,"twenty":-74.081284,"median":-46.271091,"eighty":-29.512355,"marketCap":2622587445},{"date":"2025-03-07","current":104.979059,"twenty":-72.01026,"median":-45.967027,"eighty":-29.191754,"marketCap":2533984537},{"date":"2025-03-14","current":98.262466,"twenty":-70.793997,"median":-45.867531,"eighty":-28.823085,"marketCap":2371859411},{"date":"2025-03-21","current":102.815541,"twenty":-69.1693,"median":-45.622558,"eighty":-28.456761,"marketCap":2481761540},{"date":"2025-03-28","current":100.425984,"twenty":-68.497658,"median":-45.480226,"eighty":-28.150052,"marketCap":2424082409},{"date":"2025-04-04","current":91.933369,"twenty":-67.841872,"median":-45.225885,"eighty":-27.678468,"marketCap":2219087658},{"date":"2025-04-11","current":97.681223,"twenty":-67.419943,"median":-45.18393,"eighty":-27.388744,"marketCap":2357829353},{"date":"2025-04-17","current":101.814511,"twenty":-66.902461,"median":-44.998331,"eighty":-27.21209,"marketCap":2457598661},{"date":"2025-04-25","current":103.784281,"twenty":-65.995926,"median":-44.823627,"eighty":-27.013515,"marketCap":2505144972},{"date":"2025-05-02","current":95.937492,"twenty":-65.68518,"median":-44.534449,"eighty":-26.71491,"marketCap":2315739176},{"date":"2025-05-09","current":73.607563,"twenty":-65.460728,"median":-44.285561,"eighty":-26.514847,"marketCap":2432656334},{"date":"2025-05-16","current":67.51137,"twenty":-65.460728,"median":-44.147676,"eighty":-26.313901,"marketCap":2231183267},{"date":"2025-05-23","current":64.92845,"twenty":-65.460728,"median":-43.986895,"eighty":-26.2045,"marketCap":2145820341},{"date":"2025-05-30","current":63.885803,"twenty":-65.460728,"median":-43.84417,"eighty":-26.011175,"marketCap":2111361912},{"date":"2025-06-06","current":63.933196,"twenty":-65.460728,"median":-43.736605,"eighty":-25.918892,"marketCap":2112928204},{"date":"2025-06-13","current":63.245997,"twenty":-65.460728,"median":-43.5521,"eighty":-25.777549,"marketCap":2090216967},{"date":"2025-06-20","current":63.554052,"twenty":-65.500654,"median":-43.38443,"eighty":-25.669802,"marketCap":2100397867},{"date":"2025-06-27","current":63.530356,"twenty":-65.500654,"median":-43.238236,"eighty":-25.459026,"marketCap":2099614720},{"date":"2025-07-03","current":65.189112,"twenty":-65.500654,"median":-43.101676,"eighty":-25.399624,"marketCap":2154434948},{"date":"2025-07-11","current":65.212808,"twenty":-65.13962,"median":-43.022282,"eighty":-25.2232,"marketCap":2155218094},{"date":"2025-07-18","current":57.392958,"twenty":-64.831855,"median":-42.801885,"eighty":-25.094253,"marketCap":1896779878},{"date":"2025-07-25","current":55.900078,"twenty":-64.170379,"median":-42.572884,"eighty":-24.86584,"marketCap":1847441673},{"date":"2025-08-01","current":55.710506,"twenty":-63.698031,"median":-42.387461,"eighty":-24.663707,"marketCap":1841176504},{"date":"2025-08-08","current":82.314351,"twenty":-63.698031,"median":-42.228474,"eighty":-24.536015,"marketCap":2167748432},{"date":"2025-08-15","current":89.739681,"twenty":-63.683011,"median":-41.983994,"eighty":-24.436829,"marketCap":2363294503},{"date":"2025-08-22","current":87.917404,"twenty":-63.604283,"median":-41.904528,"eighty":-24.392203,"marketCap":2315304834},{"date":"2025-08-29","current":89.470821,"twenty":-63.604283,"median":-41.69712,"eighty":-24.297955,"marketCap":2356214060},{"date":"2025-09-05","current":94.160944,"twenty":-63.613878,"median":-41.603428,"eighty":-24.214125,"marketCap":2479728453},{"date":"2025-09-12","current":95.176639,"twenty":-63.604283,"median":-41.374581,"eighty":-24.074689,"marketCap":2506476793},{"date":"2025-09-19","current":99.269294,"twenty":-63.604283,"median":-41.324883,"eighty":-23.980498,"marketCap":2614256869},{"date":"2025-09-26","current":98.044485,"twenty":-63.604283,"median":-41.209332,"eighty":-23.877018,"marketCap":2582001518},{"date":"2025-10-03","current":106.438909,"twenty":-63.604283,"median":-40.99355,"eighty":-23.745326,"marketCap":2803068680},{"date":"2025-10-10","current":104.347772,"twenty":-63.420112,"median":-40.758268,"eighty":-23.63403,"marketCap":2747998568},{"date":"2025-10-17","current":106.976631,"twenty":-63.272444,"median":-40.643374,"eighty":-23.433295,"marketCap":2817229566},{"date":"2025-10-24","current":106.468783,"twenty":-62.853962,"median":-40.427789,"eighty":-23.325552,"marketCap":2803855396},{"date":"2025-10-31","current":105.542708,"twenty":-62.539254,"median":-40.30981,"eighty":-23.161544,"marketCap":2779467204},{"date":"2025-11-07","current":108.703368,"twenty":-62.15546,"median":-40.156833,"eighty":-22.993014,"marketCap":3295560022},{"date":"2025-11-14","current":103.957863,"twenty":-62.02593,"median":-40.011843,"eighty":-22.899523,"marketCap":3151690527},{"date":"2025-11-21","current":106.513135,"twenty":-61.570174,"median":-39.830951,"eighty":-22.543606,"marketCap":3229158717},{"date":"2025-11-28","current":123.435295,"twenty":-61.276626,"median":-39.607499,"eighty":-22.439091,"marketCap":3742187849},{"date":"2025-12-05","current":123.617815,"twenty":-60.812292,"median":-39.479062,"eighty":-21.93391,"marketCap":3747721291},{"date":"2025-12-12","current":110.085301,"twenty":-59.775937,"median":-39.400551,"eighty":-21.779192,"marketCap":3337456084},{"date":"2025-12-19","current":109.615966,"twenty":-59.004338,"median":-39.267171,"eighty":-21.519912,"marketCap":3323227232},{"date":"2025-12-26","current":111.519383,"twenty":-58.495474,"median":-39.054032,"eighty":-21.28018,"marketCap":3380933129},{"date":"2026-01-02","current":109.772411,"twenty":-57.924181,"median":-38.880192,"eighty":-20.900716,"marketCap":3327970183},{"date":"2026-01-09","current":113.579245,"twenty":-57.32923,"median":-38.729689,"eighty":-20.703299,"marketCap":3443381975},{"date":"2026-01-16","current":106.904248,"twenty":-56.699295,"median":-38.54973,"eighty":-20.469262,"marketCap":3241016093},{"date":"2026-01-23","current":114.205026,"twenty":-56.465991,"median":-38.401246,"eighty":-20.358769,"marketCap":3462353777},{"date":"2026-01-30","current":101.011477,"twenty":-55.980492,"median":-38.30969,"eighty":-20.037188,"marketCap":3062364962},{"date":"2026-02-06","current":90.894685,"twenty":-55.650411,"median":-38.264113,"eighty":-19.55896,"marketCap":2755654170},{"date":"2026-02-13","current":91.650837,"twenty":-54.962607,"median":-38.122272,"eighty":39.852805,"marketCap":2778578430},{"date":"2026-02-20","current":94.597223,"twenty":-54.264343,"median":-38.015912,"eighty":55.862164,"marketCap":2867903996},{"date":"2026-02-27","current":46.164536,"twenty":-53.85672,"median":-37.966951,"eighty":57.255519,"marketCap":3063155453},{"date":"2026-03-06","current":41.529671,"twenty":-53.597054,"median":-37.842225,"eighty":57.255519,"marketCap":2755618248},{"date":"2026-03-13","current":37.039006,"twenty":-52.755398,"median":-37.689456,"eighty":57.255519,"marketCap":2457649147},{"date":"2026-03-20","current":39.254401,"twenty":-52.601771,"median":-37.637989,"eighty":57.255519,"marketCap":2604647237},{"date":"2026-03-27","current":39.278351,"twenty":-52.251287,"median":-37.571876,"eighty":57.255519,"marketCap":2606236405},{"date":"2026-04-02","current":38.799346,"twenty":-52.114238,"median":-37.437309,"eighty":57.255519,"marketCap":2574453034},{"date":"2026-04-10","current":37.54196,"twenty":-51.811908,"median":-37.355935,"eighty":57.255519,"marketCap":2491021686},{"date":"2026-04-17","current":39.553778,"twenty":-50.802171,"median":-37.246652,"eighty":57.255519,"marketCap":2624511843},{"date":"2026-04-24","current":39.697479,"twenty":-50.055625,"median":-36.954813,"eighty":57.255519,"marketCap":2634046855},{"date":"2026-05-01","current":39.587632,"twenty":-49.711179,"median":-36.817494,"eighty":57.255519,"marketCap":2626758137},{"date":"2026-05-08","current":36.953044,"twenty":-49.34063,"median":-36.67701,"eighty":57.255519,"marketCap":3252348291},{"date":"2026-05-15","current":35.266767,"twenty":-49.34063,"median":-36.581975,"eighty":57.255519,"marketCap":3103933968},{"date":"2026-05-22","current":40.969285,"twenty":-49.34063,"median":-36.356139,"eighty":57.255519,"marketCap":3605829717},{"date":"2026-05-29","current":43.507767,"twenty":-49.349881,"median":-35.977855,"eighty":57.369262,"marketCap":3829249129},{"date":"2026-06-05","current":45.275639,"twenty":-49.34063,"median":-35.733952,"eighty":57.255519,"marketCap":3984844791},{"date":"2026-06-12","current":42.991005,"twenty":-49.34063,"median":-35.325087,"eighty":57.255519,"marketCap":3783767320},{"date":"2026-06-18","current":46.49955,"twenty":-49.34063,"median":-34.436594,"eighty":57.255519,"marketCap":4092564864},{"date":"2026-06-26","current":53.081471,"twenty":-49.349881,"median":-33.57374,"eighty":57.369262,"marketCap":4671859481},{"date":"2026-07-02","current":54.260052,"twenty":-49.349881,"median":-33.033337,"eighty":57.369262,"marketCap":4775589922},{"date":"2026-07-10","current":53.761421,"twenty":-49.349881,"median":-32.372651,"eighty":57.369262,"marketCap":4731703967},{"date":"2026-07-17","current":53.688893,"twenty":-49.349881,"median":-31.565405,"eighty":57.369262,"marketCap":4725320555},{"date":"2026-07-24","current":52.474048,"twenty":-49.349881,"median":-31.141244,"eighty":57.369262,"marketCap":4618398408},{"date":"2026-07-31","current":41.665614,"twenty":-49.35355,"median":-30.375408,"eighty":57.374001,"marketCap":4770004437},{"date":"2026-08-07","current":32.40684,"twenty":-49.222748,"median":-29.992215,"eighty":57.374001,"marketCap":3710032235},{"date":"2026-08-14","current":29.914006,"twenty":-48.918745,"median":-29.50942,"eighty":57.374001,"marketCap":3424645140},{"date":"2026-08-21","current":29.345218,"twenty":-48.918745,"median":-29.203367,"eighty":57.374001,"marketCap":3359528648},{"date":"2026-08-28","current":31.774854,"twenty":-48.789739,"median":-28.825294,"eighty":57.374001,"marketCap":3637680577},{"date":"2026-09-04","current":31.367574,"twenty":-48.58868,"median":-28.46853,"eighty":57.374001,"marketCap":3591053953},{"date":"2026-09-11","current":29.513748,"twenty":-48.39188,"median":-28.211045,"eighty":57.374001,"marketCap":3378822423},{"date":"2026-09-16","current":28.186577,"twenty":-48.337466,"median":-27.943593,"eighty":57.374001,"marketCap":3226883942}],"updateTime":1789642004022},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"VCYT\",pageSize:20,pageCount:4,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2640928355","title":"Veracyte posts investor presentation outlining growth strategy for genomic cancer diagnostics portfolio","url":"https://stock-news.laohu8.com/highlight/detail?id=2640928355","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640928355?lang=en_us&edition=fundamental","pubTime":"2026-06-03 03:04","pubTimestamp":1780427050,"startTime":"0","endTime":"0","summary":"Veracyte outlined plans to launch the Prosigna LDT on June 8, 2026, targeting ER+/HER2- breast cancer patients.Management framed the eligible US population at about 225,000 newly diagnosed ER+/HER2- breast cancer cases annually.The presentation highlighted OPTIMA as supporting Prosigna-directed chemotherapy decisions in a broad high-risk patient group.Prosigna clinical evidence base cited 157 breast-related publications, described as growing.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Veracyte Inc. published the original content used to generate this news brief on June 02, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260602:nNDL2Wf1h9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","VCYT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640748917","title":"Needham Raises Price Target on Veracyte to $57 From $48, Keeps Buy Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2640748917","media":"MT Newswires Live","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640748917?lang=en_us&edition=fundamental","pubTime":"2026-06-02 19:29","pubTimestamp":1780399740,"startTime":"0","endTime":"0","summary":"Veracyte (VCYT) has an average rating of overweight and mean price target of $48.80, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from major ban","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate","earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["VCYT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640627909","title":"Veracyte assumed with an Outperform at Wolfe Research","url":"https://stock-news.laohu8.com/highlight/detail?id=2640627909","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640627909?lang=en_us&edition=fundamental","pubTime":"2026-06-02 04:47","pubTimestamp":1780346840,"startTime":"0","endTime":"0","summary":"Wolfe Research assumed coverage of Veracyte (VCYT) with an Outperform rating and price target of $55, up from $50. The company’s testing assets, Af...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/veracyte-assumed-with-an-outperform-at-wolfe-research-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/veracyte-assumed-with-an-outperform-at-wolfe-research-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["VCYT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640680439","title":"Veracyte Is Maintained at Buy by Needham","url":"https://stock-news.laohu8.com/highlight/detail?id=2640680439","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640680439?lang=en_us&edition=fundamental","pubTime":"2026-06-01 23:32","pubTimestamp":1780327920,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/VCYT/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  June 01, 2026 11:32 ET (15:32 GMT)","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VCYT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640974968","title":"Veracyte Inc : Needham Raises Target Price to $57 From $48","url":"https://stock-news.laohu8.com/highlight/detail?id=2640974968","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640974968?lang=en_us&edition=fundamental","pubTime":"2026-06-01 23:07","pubTimestamp":1780326461,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260601:nFWN4290OF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["VCYT","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640517639","title":"Veracyte posts investor presentation on ASCO findings","url":"https://stock-news.laohu8.com/highlight/detail?id=2640517639","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640517639?lang=en_us&edition=fundamental","pubTime":"2026-06-01 20:34","pubTimestamp":1780317278,"startTime":"0","endTime":"0","summary":"Veracyte published an investor presentation highlighting ASCO data on Prosigna in the OPTIMA phase III trial for ER-positive, HER2-negative early breast cancer.In the per-protocol ROR ≤60 group, 5-year invasive breast cancer-free survival was 93.6% in the test-directed arm versus 94.8% in the control arm.Adjusted hazard ratio was 1.06 with a 90% CI of 0.80-1.40; non-inferiority met with p=0.003.Across the broader low-risk analysis shown, 5-year invasive breast cancer-free survival was 90.3% versus 91.8%; adjusted hazard ratio 1.03, 90% CI 0.85-1.25.Presentation also cited Decipher evidence in metastatic prostate cancer from ENZAMET, using DGC >0.85 to identify docetaxel benefit with ADT, enzalutamide.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or l","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260601:nNDL2thmt0:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VCYT","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2639480988","title":"Veracyte announces results from Enzamet trial presented at 2026 ASCO meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2639480988","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2639480988?lang=en_us&edition=fundamental","pubTime":"2026-05-31 21:36","pubTimestamp":1780234597,"startTime":"0","endTime":"0","summary":"Veracyte (VCYT) announced results from the Enzamet trial presented at the 2026 ASCO Annual Meeting. The analysis demonstrates that the Decipher Pro...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/veracyte-announces-results-from-enzamet-trial-presented-at-2026-asco-meeting-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/veracyte-announces-results-from-enzamet-trial-presented-at-2026-asco-meeting-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["VCYT","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2639515609","title":"Veracyte - Enzamet Trial Shows Decipher Prostate Test Identifies Chemotherapy Benefit in Metastatic Prostate Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2639515609","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2639515609?lang=en_us&edition=fundamental","pubTime":"2026-05-30 20:10","pubTimestamp":1780143023,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260530:nFWN4261DV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["VCYT","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2639582609","title":"Veracyte says ENZAMET trial shows Decipher Prostate test flags metastatic patients who benefit from adding docetaxel","url":"https://stock-news.laohu8.com/highlight/detail?id=2639582609","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2639582609?lang=en_us&edition=fundamental","pubTime":"2026-05-30 20:00","pubTimestamp":1780142431,"startTime":"0","endTime":"0","summary":"Veracyte disclosed results already presented at the 2026 ASCO meeting from a biomarker analysis of the Phase III ENZAMET trial.The Decipher Prostate test identified metastatic prostate cancer patients likely to benefit from adding docetaxel to standard hormonal therapy.Patients with lower-risk genomic profiles showed no added benefit from chemotherapy, supporting treatment de-escalation in that group.The readout positions Decipher as a decision tool for selecting triplet therapy, potentially expanding clinical adoption in advanced disease.Separate ASCO data in high-risk localized disease supported broader use by improving risk stratification beyond standard clinical factors.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260530:nNDL6Dvgjh:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VCYT","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2639672488","title":"Veracyte Says Prosigna Test Can Help High-Risk Breast Cancer Patients Avoid Chemotherapy","url":"https://stock-news.laohu8.com/highlight/detail?id=2639672488","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2639672488?lang=en_us&edition=fundamental","pubTime":"2026-05-30 04:00","pubTimestamp":1780084814,"startTime":"0","endTime":"0","summary":"Veracyte  said results from an independent Phase 3 trial show its Prosigna Breast Risk of Recurrence test can safely guide adjuvant chemotherapy decisions for patients with early-stage, ER-positive, HER2-negative breast cancer.The study, led by University College London, enrolled 4,429 patients and had a median follow-up of four years, Veracyte said Friday in a statement. Investigators reported that Prosigna provided Level 1A evidence, demonstrating the test can accurately predict chemotherapy benefit and support safe treatment de-escalation across high-risk groups.The results will be presented Saturday at the annual meeting of the American Society of Clinical Oncology.Price: 46.32, Change: -1.67, Percent Change: -3.48","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4139","VCYT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2639767442","title":"Veracyte says OPTIMA trial shows Prosigna test helps 68% of high-risk breast cancer patients avoid chemotherapy","url":"https://stock-news.laohu8.com/highlight/detail?id=2639767442","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2639767442?lang=en_us&edition=fundamental","pubTime":"2026-05-30 03:15","pubTimestamp":1780082122,"startTime":"0","endTime":"0","summary":"Veracyte announced OPTIMA Phase III trial results for its Prosigna breast cancer test, with findings set for presentation May 30 at ASCO 2026.The study found the test can guide treatment choices so many clinically high-risk early-stage patients can skip chemotherapy without worsening outcomes.Results support wider adoption of Prosigna to reduce chemotherapy use in hormone receptor-positive, HER2-negative breast cancer, including node-positive disease.Veracyte framed the data as the strongest prospective evidence for Prosigna in predicting chemotherapy benefit, strengthening its competitive position in genomic testing.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Veracyte Inc. published the original content used to generate this news ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260529:nNDL37tNkT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VCYT","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2639467425","title":"Veracyte - Optima Trial Shows Prosigna Test Identifies High-Risk Breast Cancer Patients Who Can Avoid Chemotherapy","url":"https://stock-news.laohu8.com/highlight/detail?id=2639467425","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2639467425?lang=en_us&edition=fundamental","pubTime":"2026-05-30 03:15","pubTimestamp":1780082117,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260529:nFWN4261MR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","VCYT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638431662","title":"Veracyte Price Target Maintained With a $48.00/Share by Needham","url":"https://stock-news.laohu8.com/highlight/detail?id=2638431662","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638431662?lang=en_us&edition=fundamental","pubTime":"2026-05-28 18:39","pubTimestamp":1779964740,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/VCYT/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  May 28, 2026 06:39 ET (10:39 GMT)","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VCYT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638026635","title":"Veracyte VP, Chief Accounting Officer Jonathan Wygant sells 24,000 shares for $1.09 million","url":"https://stock-news.laohu8.com/highlight/detail?id=2638026635","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638026635?lang=en_us&edition=fundamental","pubTime":"2026-05-28 04:19","pubTimestamp":1779913194,"startTime":"0","endTime":"0","summary":"Veracyte VP, Chief Accounting Officer Jonathan Wygant exercised stock options to buy 24,000 shares on May 22, 2026 at USD 24.8.Wygant sold 24,000 shares the same day at a weighted average price of USD 45.4.His direct holdings fell to 45,434 shares following the transactions.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Veracyte Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on May 27, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260527:nNDLcnqFV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Veracyte VP, Chief Accounting Officer Jonathan Wygant sells 24,000 shares for $1.09 million","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","VCYT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638254924","title":"Health Rounds: Veracyte genomic test identifies breast cancer patients who can skip chemo","url":"https://stock-news.laohu8.com/highlight/detail?id=2638254924","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638254924?lang=en_us&edition=fundamental","pubTime":"2026-05-27 00:55","pubTimestamp":1779814548,"startTime":"0","endTime":"0","summary":"Health Rounds: Veracyte genomic test identifies breast cancer patients who can skip chemoHealth Rounds is published on Tuesdays and Thursdays. Think your friend or colleague should know about us?Forward this newsletter to them. They can also subscribe hereBy Nancy LapidMay 26  - Hello Health Rounds readers!","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260526:nL1N41Z0Z6:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE0002270589.USD","IE00BBT3K403.USD","SG9999002232.USD","LU0321505439.SGD","BK4550","LU0868494617.USD","LU1023059063.AUD","LU1057294990.SGD","LU1066051498.USD","LU0122379950.USD","IE00B19Z3B42.SGD","SG9999001176.SGD","IE00B19Z3581.USD","LU0985481810.HKD","PFE","BK4533","BK4599","LU0289739699.SGD","SG9999002224.SGD","IE00BLSP4452.SGD","IE00BLSP4239.USD","BK4568","BK4534","LU0306806265.USD","LU1894683348.USD","LU0225771236.USD","SG9999001176.USD","LU0234572021.USD","IE000M9KFDE8.USD","LU1066053197.SGD","BK4139","IE00B3T34201.USD","SGXZ57979304.SGD","BK4585","LU0058720904.USD","VCYT","LU0321505868.SGD","LU0170899867.USD","SG9999013999.USD","BK4592","SG9999003800.SGD","LU0306807586.USD","BK4588","LU0225284248.USD","BK4007","LU1894683264.USD","LU1883839398.USD","SG9999011175.SGD","LU0456855351.SGD","BK4581"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637374556","title":"Analysts Are Bullish on These Healthcare Stocks: Veracyte (VCYT), Decibel Cannabis Company (DBCCF)","url":"https://stock-news.laohu8.com/highlight/detail?id=2637374556","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637374556?lang=en_us&edition=fundamental","pubTime":"2026-05-24 09:30","pubTimestamp":1779586207,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Veracyte (VCYT) and Decibel Cannabis Company (DBCCF)...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-these-healthcare-stocks-veracyte-vcyt-decibel-cannabis-company-dbccf-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-these-healthcare-stocks-veracyte-vcyt-decibel-cannabis-company-dbccf-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["VCYT","BK4007","DBCCF","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637344405","title":"Veracyte director Robert S. Epstein sells 10,000 shares for $440,129","url":"https://stock-news.laohu8.com/highlight/detail?id=2637344405","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637344405?lang=en_us&edition=fundamental","pubTime":"2026-05-23 04:39","pubTimestamp":1779482390,"startTime":"0","endTime":"0","summary":"Veracyte director Robert S. Epstein sold 10,000 shares of common stock on May 20, 2026.The shares were sold at a weighted average price of USD 44.01.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Veracyte Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on May 22, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260522:nNDL5yl95h:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Veracyte director Robert S. Epstein sells 10,000 shares for $440,129","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VCYT","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637350378","title":"Veracyte says OPTIMA trial backs Prosigna-guided chemotherapy decisions in breast cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2637350378","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637350378?lang=en_us&edition=fundamental","pubTime":"2026-05-22 06:00","pubTimestamp":1779400823,"startTime":"0","endTime":"0","summary":"Veracyte flagged new phase III data for its Prosigna Breast test in the OPTIMA trial, with results scheduled for presentation at the ASCO annual meeting in Chicago on May 30, 2026.The company positioned the findings as supporting Prosigna-guided decisions on adjuvant chemotherapy in high clinical-risk, early-stage breast cancer, aiming to help clinicians identify patients who can safely avoid chemotherapy.Separate ENZAMET phase III analyses tied to the Decipher Prostate test are also due at ASCO on May 30, 2026, framing the test as a tool to identify metastatic prostate cancer patients most likely to benefit from treatment intensification while steering others away from unnecessary chemotherapy.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260521:nNDL5PXhrN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VCYT","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637350367","title":"Optima Trial Results to Be Presented at Asco Provide New Evidence Supporting Prosigna-Guided Chemotherapy Decisions in Breast Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2637350367","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637350367?lang=en_us&edition=fundamental","pubTime":"2026-05-22 06:00","pubTimestamp":1779400800,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260521:nTUA9THMHL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","VCYT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637878105","title":"Why Veracyte (VCYT) Is Up 5.4% After Medicare Backs Its TrueMRD Bladder Cancer Test","url":"https://stock-news.laohu8.com/highlight/detail?id=2637878105","media":"Simply Wall St.","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637878105?lang=en_us&edition=fundamental","pubTime":"2026-05-21 03:33","pubTimestamp":1779305595,"startTime":"0","endTime":"0","summary":"Earlier in May 2026, Veracyte announced that its TrueMRD Monitoring Test for muscle-invasive bladder cancer recurrence had secured Medicare coverage from CMS under the MolDX program, with commercial availability set to begin on June 1, 2026.\nThis decision not only supports clinical use of Veracyte’s first molecular residual disease offering, but also highlights its position as the only truly whole-genome MRD test currently available, potentially broadening its role in cancer care...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-vcyt/veracyte/news/why-veracyte-vcyt-is-up-54-after-medicare-backs-its-truemrd","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-vcyt/veracyte/news/why-veracyte-vcyt-is-up-54-after-medicare-backs-its-truemrd","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["VCYT","BK4139"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":6,"pageCount":4,"totalSize":116,"code":"91000000","status":"200"}]}}